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Abstract: The 8-nitroguanine lesion in DNA is increasingly 
associated with inflammation-related carcinogenesis, whilst the 
same modification on guanosine 3’,5’-cyclic monophosphate 
generates a second messenger in NO-mediated signal transduction. 
Very little is known about the chemistry of 8-nitroguanine nucleotides, 
despite the fact that their biological effects are closely linked to their 
chemical properties. To this end, a selection of chemical reactions 
have been performed on 8-nitroguanine nucleosides and 
oligodeoxynucleotides. Reactions with alkylating reagents reveal 
how the 8-nitro substituent affects the reactivity of the purine ring, by 
significantly decreasing the reactivity of the N2 position, whilst the 
relative reactivity at N1 appears to be enhanced. Interestingly, the 
displacement of the nitro group with thiols results in an efficient and 
specific method of labelling this lesion and is demonstrated in 
oligodeoxynucleotides. Additionally, the repair of this lesion is also 
shown to be a chemically feasible reaction through a reductive 
denitration with a hydride source. 
Introduction 
The guanine base in DNA is particularly sensitive to chemical 
modification1 by reactive oxygen species and reactive nitrogen 
species (RNS) and a number of mutagenic lesions, such as 8-
nitro-2’-deoxyguanosine2 (8-nitro-dG, 1a, Figure 1) and the more 
widely studied 8-oxo-2’-deoxyguanosine3 (8-oxo-dG, 2a) are 
associated with these reactive species. A characteristic of 8-
nitrodG is that the nitro group labilises the glycosidic bond to 
release 8-nitroguanine (8-nitroG), leaving an apurinic site in the 
DNA.4 The mutagenic nature of 8-nitrodG results from both the 
generation of apurinic sites5 in the DNA and the mispairing of 8-
nitrodG6-8 during DNA synthesis; both these events lead to G to 
T transversion mutations. 
 The RNS, which are responsible for the nitrative damage 
are generated particularly at sites of inflammation, due to over-
expression of nitric oxide synthase and given the mutagenic 
nature of 8-nitro-dG, it is not surprising that this lesion is 
increasingly linked with inflammation-related carcinogenesis.9 
Specific antibodies raised against 8-nitroG have been used to 
show that 8-nitroG is present in surgically-removed human 
tissues from the sites of cancers that are caused by chronic 
inflammation9 and the accumulation of 8-nitroG is also 
associated with a poor prognosis of inflammation-induced 
cancers.9,10 Thus, 8-nitroG is progressively seen as a 
biochemical marker for DNA damage and as potential indicator 
of inflammation-induced cancers.  Nitration of the guanine base 
also occurs in the ribonucleotide pool and 8-nitroguanosine-3’,5’-
cyclic phosphate11 (8-nitro-cGMP) has attracted attention as an 
electrophilic second messenger that is involved in an unusual 
post translational modification of proteins. This process of 
protein S-guanylation,11 results from the nucleophilic sulfhydryl 
group of a cysteine residue displacing the nitro group of  8-nitro 
cGMP. More recently H2S, a proposed gaseous transmitter in 
mammals, has been shown to react with and sequester 8-nitro-
cGMP, and provides a potential mechanism to shut down this 
electrophile-mediated signalling pathway.12  
  
 
Figure 1.  
 Collectively these diverse studies have shown that the 
chemical properties of 8-nitroguanine nucleotides are inherently 
related to their biological function and have encouraged us to 
look more closely at their chemistry.  We now report our studies 
on some chemical reactions performed on 8-nitroguanine 
nucleosides and oligonucleotides. The results shed some light 
on how the 8-nitro substituent affects the reactivity of the purine 
ring, they demonstrate that the 8-nitroguanine lesion in DNA can 
be fluorescently labelled and raise the possibility of a repair 
mechanism for this lesion. 
Results and Discussion 
Alkylation reactions- Previous studies have demonstrated that 
some chemical properties of guanine nucleosides are 
significantly altered by introduction of the 8-nitro group. The nitro 
group greatly enhances the hydrolytic lability of the glycosidic 
bond4 and also significantly lowers the pKa of the proton on N1 
(pKa = 8.4 for 8-nitroguanosine compared to 9.4 for guanosine).8 
O
R1O
HN
N
N
N
O
H2N
R1O R2
NO2 O
HO
HN
N
N
NH
O
H2N
HO R
O
1a, R1 = R2 = H = 8-nitro-dG                         2a, R = H = 8-oxo-dG 
1b, R1 = H, R2 = OH, 8-nitro-rG                    2b, R = OMe
1c, R1 = CH3CO, R2 = OAc
1d, R1 = H, R2 = OMe
 Dr. K.J. Alexander, Dr. M. McConville, Kathryn R. Williams, Dr. K. V. 
Luzyanin, Dr. I. A. O’Neil and Prof. R. Cosstick 
Department of Chemistry,  
 University of Liverpool,  
 Crown Street, Liverpool,  
L69 7ZD, (UK) 
 Supporting information for this article is given via a link at the end of 
the document. 
FULL PAPER    
 
 
 
 
 
In addition, we have made attempts to introduce the usual acyl 
or formamidine protecting groups at the N2 position of 8-nitroG 
nucleosides, but were unable to prepare these derivatives using 
routine procedures.8 This failure to derivatise the N2 position 
implied that the reactivity of the guanine base is significantly 
reduced because of the strongly electron withdrawing nitro 
group and suggested that the chemistry of 8-nitroguanine 
nucleosides required wider exploration.  
 
 
Scheme 1. Reactions of 2’,3’,5’-tri-O-acetyl-8-nitroguanosine with quinone 
methides. Experimental  details in the Supplementary Information. 
 We chose to investigate alkylation reactions on 2’,3’,5’-tri-
O-acetyl-8-nitroguanosine (1c, Figure 1), as in this substrate the 
electron withdrawing acetyl groups, particularly on the 2’-OH, 
help to further stabilise the glycosidic bond. Given the seemingly 
inert nature of the 8-nitroguanine base, ortho- and para-quinone 
methides were selected as alkylating agents as they possess a 
benzylic carbon which is highly electron deficient and extremely 
susceptible to nucleophilic attack.13,14 In addition, the products of 
the reactions of these quinone methides with 2’-deoxyguanosine 
have been well characterised.13,14 
 In initial experiments, acetylated 8-nitroguanosine (1c) was 
reacted with a molar equivalent of the para-quinone methide (p-
QM) prepared from 2,6-bis(tert-butyl)-4-methylphenol by 
oxidation with silver (I) oxide (Scheme 1).13 Under these 
conditions TLC and HPLC showed that a single nucleoside 
product (3) was formed and was subsequentlty isolated in 68% 
yield following column chromatography. Mass spectrometry 
ascertained that (3) was a monoalkylated product and N1 was 
established as the position of alkylation through NMR 
techniques. DEPT 135 established the presence of two CH2 
groups and through HSQC and COSY experiments benzylic 
protons  from the quinone methide adduct were identified as a 
singlet at 5.11ppm. In the 13C NMR spectrum the benzylic signal 
resonated at 45.70ppm, characteristic of a carbon-nitrogen 
bond; a chemical shift of approximately 70ppm would be 
expected should the benzylic carbon have been attached to an 
oxygen atom. From the 1H NMR it was possible to determine 
which nitrogen atom was alkylated. Acquisition of the spectra in 
a non-protic solvent indicated the absence of the signal 
corresponding to the N1 proton which was present in the starting 
material at 11.34ppm. Additionally, the broad peak at 6.06ppm 
corresponding to the N2 signal integrated to 2 protons. These 
observations confirm that alkylation occurred at the N1 position. 
This assignment was further strengthened when compared to 
the N2 alkylated product previously characterised from  the 
reaction between deoxyguanosine and a para-quinone 
methide,13 in which these observations were reversed; the peak 
at 10.35ppm associated with the N1 proton was present and the 
signal associated with the N2 proton integrated as a single 
proton. 
 We also examined the alkylation of acetylated 8-
nitroguanosine  with an ortho-quinone methide (o-QM) produced 
from 2-bromomethyl-O-tert-butyldimethyl-silylphenol using 
potassium fluoride (Scheme 1).15,16 In an initial experiment with 
one equivalent of the o-QM, two products were observed by 
HPLC; a more polar product (~40%) and a less polar product 
(~5%). When four molar equivalents of o-QM were used a more 
even distribution of the products was obtained and the more 
polar and less polar products were isolated in yields of 40% and 
27%, respectively. Mass spectrometry revealed the more polar 
(4) and less polar (5) products to be mono-alkylated and di-
alkylated species, respectively (Scheme 1). NMR techniques 
revealed the mono-alkylated product (4) to be entirely consistent 
with the N1-ortho quinone methide, based on similarities to the 
N1-para quinone methide product (3). 
 For the dialkylated product (5), the presence of two non-
nucleosidic CH2 groups with chemical shifts of 67.36ppm and 
40.00ppm in the 13C NMR spectrum, was established. These 
resonances are characteristic of a benzylic carbon-oxygen bond 
and a benzylic carbon-nitrogen bond, respectively and therefore 
indicated that O6 is one of the alkylation sites.14,17 With regard to 
the second alkylation site on nitrogen, alkylation at the N1 
position seemed unlikely. This was supported by 1H NMR 
spectra recorded in a non-protic solvent revealed the presence 
of a single NH signal which integrated to one proton. 
 The results of alkylation reactions performed here with 
2’,3’,5’-tri-O-acetyl-8-nitroguanosine  (1c) show significant 
differences to those previously reported for 2’-deoxyguanosine 
(dG), both in terms of the products formed and their distribution. 
For example, the sole nucleoside product isolated from 
alkylation of (1c) with p-QM is the N1 adduct (3), whereas 
previous results obtained with dG show N2 to be the favoured 
site of alkylation.14 That the 8-nitro group leads to preferential 
reaction at N1 rather than N2 is not so surprising given that the 
lone pair on N2 is directly conjugated through to the nitro group 
(Scheme 2) and that  reaction at N1 of the nitrated nucleoside 
might be enhanced by deprotonation, due to its significantly 
lower pKa. 
 The reaction of excess o-QM with nitrated nucleoside (1c) 
once again gave the N1 adduct (4) as the major product (40%), 
together with the O6,N2-dialkylated product (5, 27%). Alkylation 
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at N1 was expected based on the result obtained with p-QM, 
particularly since the use of excess potassium fluoride to 
generate the o-QM in unbuffered conditions, would be expected 
to lead to mildly basic conditions that favour reaction at N1 due 
to deprotonation. The O6,N2-dialkylated product was 
unexpected, since no O6 or N2 mono-alkylated products were 
observed. The ortho geometry of the o-QM means that 
hydrogen-bonding of NH1 with the carbonyl group of the 
quinone methide could assist nucleophilic attack by either O6 or 
N2 (Scheme 2). Given, that N2 appears to be highly deactivated, 
attack by O6 is likely to be favoured from the hydrogen-bonded 
complex. In order to explain why no O6 mono-alkylated product 
is observed, the subsequent alkylation on N2, would have to be 
relatively fast and might be assisted by the alkylated and 
therefore electron donating O6. In contrast, studies on the 
reaction between dG and o-QM have been shown to give N2 
alkylation as either the sole product18 or to favour N2 alkylation 
over N1 by a factor of about 5.14 
 
Scheme 2. Panel A shows O6 versus N2 hydrogen bond-directed alkylation, 
resulting in initial alkylation at the presumably more reactive O6 position and 
subsequent alkylation at N2, to give dialkylated 5. Panel B shows reduced 
nucleophilicity of N2 because of conjugation through to the nitro group. 
 The alkylation reactions reported here have been 
performed on 2’,3’,5’-tri-O-acetyl-8-nitroguanosine in order to 
reduce depurination and were also optimised to generate good 
yields of the products to aid their characterisation, therefore the 
reaction outcomes cannot be directly compared with quantitative 
studies previously obtained with dG. However, given that the 
sites of alkylation for DNA bases with quinone methides remain 
constant in their deoxynucleoside, single-stranded 
oligodeoxynucleotide and duplex polydeoxynucleotide forms,18 
the presence of the acetyl protecting groups on the sugar is not 
expected to alter the site of alkylation. Thus, the results 
presented here indicate that the reactivity of the guanine base is 
significantly altered by the introduction of the 8-nitro group; the 
reactivity of the N2 position significantly decreases whilst N1 
appears to be enhanced, presumably due to its considerably 
lower pKa. 
 Reductive denitration of 8-nitroguanosine- Aromatic 
nitro compounds such as nitroimidazoles have emerged as 
potent anti-TB pro-drugs that exert their activity through the 
release of nitric oxide (NO), which is the effective agent.19 NO 
released from these drugs is initiated by nucleophilic attack of a 
hydride equivalent from a deazaflavin cofactor that is present in 
a deazaflavin-dependent nitroreductase and the overall reaction 
is a denitration in which NO2 is replaced by H.19 A related 
reaction performed on the 8-nitroG lesion in DNA, in which a 
hydride equivalent was delivered to the C8 position, could 
remove the nitro group through an addition-elimination reaction, 
thus suggesting a potential DNA repair mechanism by directly 
reversing the lesion. Relatively few DNA lesions are repaired by 
direct chemical reversal, but this route is well established for the 
repair of UV-induced pyrimidine dimer lesions20 and the repair of 
guanine O6 alkylation products by O6-alkylguanine DNA 
alkyltransferase.21  We were therefore interested in investigating 
the chemical feasibility of  reducing 8-nitroguanosine back to 
guanosine as this could suggest a potential repair mechanism 
for this lesion by direct chemical reversal. 
 There are a few examples where borohydride has been 
used to effect aromatic denitration and these have been 
reported for both polysubstituted nitrobenzenes22,23 and 
heterocyclic systems.24 These reactions take place through an 
addition elimination mechanism in which nitrite is displaced by 
hydride.23 Earlier studies25 on the characterisation of the 8-
nitroguanine base have shown that reducing agents such as: 
sodium hydrosulfite; zinc-HCl; hydrazine hydrate-Raney nickel, 
all yield the expected 8-aminoguanine, but to our knowledge the 
reaction has not been studied with hydride reducing agents. 
  
 
Scheme 3. Reduction of 8-nitroG with sodium borohydride. 
 Prior to studying the reduction, 8-nitroguanosine (1b, 
Figure 1) was purified by reverse-phase (RP)-HPLC, although 
as can be seen in Figure 2, a small amount of the depurination 
product 8-nitroguanine was unavoidably introduced into the 
starting samples of 8-nitroguanosine during evaporation of the 
fractions. It was also necessary to develop RP-HPLC conditions 
that would separate the two most likely products; namely 8-
aminoguanosine and guanosine. An extensive investigation of 
eluents revealed that 8-aminoguanosine and guanosine were 
readily separated using a gradient of acetonitrile in aqueous 
Sugar
N
N N
N
O
N
H
NO2
6
2
O
H
O6-alkylated
dialkylated (5)
SugarSugar
HN
N N
N
O
H2N
N
O
O
O
A
B
H
SugarSugar
HN
N N
N
O
H2N
N
O
O
8-nitro-rG
1b
HN
N N
N
O
H2N
R
HN
N N
N
O
H2N
R
NH2
guanosine 8-aminoguanosine
R =  β-D-ribofuranosyl-1-yl
O
O NH
NN
N
O
NH2
HO OH
8,5'-O-cyclo-guanosine
 NaBH4
H2O
FULL PAPER    
 
 
 
 
 
acetic acid (0.1% AcOH) and these elution conditions were also 
compatible with HPLC-MS. 
 
 
Figure. 2. RP-HPLC analysis of the reduction of 8-nitroguanosine with sodium 
borohydride. Details of the reaction conditions are described in the 
Experimental section. HPLC chromatograms were obtained using an elution 
gradient of 0-20% acetonitrile in 0.1% aqueous acetic acid over 20 min, with a 
flow rate of 0.5 ml/min. Chromatograms were recorded at 254 nm. 
Table 1. High-resolution mass data for the borohydride (either NaBH4 or 
NaBD4) reduction of 8-nitroguanosine as shown in Scheme 3. Accurate mass 
measurements were obtained by LC-MS as described in the experimental 
section. Mass spectra for individual compounds are shown in the SI. 
Nucleoside Formula Calculated 
exact mass for 
[M-H]
-
 
Measured 
accurate mass 
for [M-H]
-
 
Guanosine C10H13N5O5 282.0844 282.0827 
8-Deuteroguanosine C10H12DN5O5 283.0907 283.0906  
8,5’-O-Cycloguanosine C10H11N5O5 280.0687 280.0693 
8-Aminoguanosine C10H14N6O5 297.0953 297.0963 
 
 Reduction reactions (Scheme 3) were generally performed 
in unbuffered distilled water using a very large excess of sodium 
borohydride that was repeatedly added at regular intervals to 
compensate for hydrolysis. Under these conditions a slow 
reduction occurred (Figure 2) that gave 8-aminoguanosine as 
the major product together with a small amount (8-10%) of 
guanosine (Scheme 3). The identity of both products was 
confirmed by co-elution with authentic samples of guanosine 
and 8-aminoguanosine and also by HPLC-MS analysis (see 
Figure 2, Table 1 and SI). In addition to the reduction products, 
an additional nucleoside product (~20%) was observed that was 
identified by HPLC-MS as 8,5’-O-cycloguanosine and 
presumably results from displacement of the nitro group by the 
5’-hydroxyl group. Formation of the cyclo-nucleoside is probably 
facilitated by the rise in pH caused by hydrolysis of the 
borohydride. 
 Further proof for the direct displacement of the nitro group 
by hydride was obtained by performing the reaction using NaBD4 
in H2O, and in this case HPLC-MS revealed the guanosine 
fraction to have the correct mass for the incorporation of one 
deuterium atom (see Table 1).  As expected, the peak 
corresponding to 8-aminoguanosine showed no inclusion of 
deuterium as any incorporated during reduction would exchange 
through protonation. 
 In an attempt to increase the proportion of guanosine, the 
reduction was investigated under a variety of conditions. Using 
buffered aqueous conditions between pHs 6.0 – 9.0 (0.1M 
ammonium acetate) there was little difference in terms of the 
product distribution from those performed in water, although the 
reaction at lower pH did progress slightly faster. It is not 
surprising that all the aqueous reduction reactions gave similar 
results as the very large excess of borohydride, which raises the 
pH as it is hydrolysed, resulted in all these reactions becoming 
alkaline as the reaction proceeded (pH ~ 9.6 at the end of the 
reaction).  No reduction products were observed when the 
weaker reducing agent sodium cyanoborohydride was used at 
pH 6.0.  The work of Lamson23a has established that the 
denitration of polysubstituted nitrobenzenes  proceeded more 
rapidly in DMSO than in protic solvents. However, when the 
reaction was performed in DMSO we were unable to detect any 
reduction products, even during a prolonged reaction (>1 week) 
and only a trace amount of 8,5’-O-cycloguanosine was formed. 
 Whilst we have been unable to increase the proportion of 
guanosine above about 12%, its formation by displacement of 
the nitro group by a hydride equivalent, in aqueous solution, 
does clearly show that a direct repair of the 8-nitroguanine lesion 
is a chemically feasible reaction. 
 
Detection of 8-nitroguanine through the displacement of the 
nitro group by thiols- Methods have been developed to detect 
the 8-nitroguanine base in tissues9,10 and urine,26  but these 
methods are only applicable once the 8-nitroguanine base has 
been hydrolytically released from DNA and they give no 
information as to the steady-state levels of  this lesion in DNA 
samples. We have recently shown that surface-enhanced 
Raman spectroscopy is a very sensitive technique for detecting 
this lesion due to the nitro group and can distinguish between 
the 8-nitroguanine that is covalently bound to DNA or has been 
released by hydrolysis.27  
 The displacement of the nitro group in 8-nitroguanine 
nucleosides by sulfur nucleophiles is well established and 
specific examples include the capture of 8-nitroguanosine by the 
nucleoside derivative nitroG-Grasp,28 sulfhydration12  and protein 
S-guanylation29  of  8-nitro-cGMP. The mild conditions for these 
displacement reactions suggested that it might be possible to 
develop a detection procedure for this lesion based on 
displacement of the nitro group with a fluorescent thiol. In theory, 
each lesion site would be converted to a fluorescently labelled 
guanine base that would be stable to depurination (due to the 
loss of the strongly electron withdrawing nitro group) and thus 
create a permanent and quantifiable record of the lesion sites, 
which in theory could be identifiable through sequencing 
methods.  
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  As 8-nitro-dG (1a), which is the naturally occurring lesion 
in DNA readily undergoes depurination, our initial experiments to 
explore this labelling technique were performed on 8-
nitroguanosine (1b, Figure 1) and 8-nitro-2’-O-methylguanosine 
(1d, , Figure 1). Both of these ribonucleosides have a more 
stable glycosidic bond than their 2’-deoxy counter part, due to 
the electronegative 2’-oxygen. The 2’-O-methylriboside is also 
ideally suited as a means to incorporate this lesion into 
oligonucleotides, as no protection of the 2´-position is necessary 
during DNA synthesis and it has previously been used as a 
model for 8-nitro-dG in oligonucleotides.8 We chose to use N-
(tert-butoxycarbonyl)cysteine ethyl ester (6, Scheme 4) as a 
model thiol as its hydrophobicity was expected to significantly 
increase the retention time of the resulting 
nucleoside/oligonucleotide adducts on reverse-phase HPLC and 
its low extinction coefficient at 260 nm, was not expected to 
significantly interfere with the HPLC analysis. Thus, reaction of 
8-nitroguanosine with a slight excess of cysteine thiol (6) in 
aqueous buffer (pH 7.5), gave the S-guanylated cysteine 
derivative (7b) in good yield (69%).30 Analysis of 1H-13C HMBC 
contour map revealed a long range 1H-13C correlation between 
the C8 resonance and the protons adjacent to the sulfur atom, 
thus confirming that the sulfur atom had displaced the nitro 
group. A similar yield (72%) was obtained for the conversion 8-
nitro-2’-O-methylguanosine (1d) to its corresponding 8-S-
cysteinyl derivative (7d, Scheme 4). 
 
 
Scheme 4. Reaction of thiols with 8-nitroguanosine nucleosides. Compound 8 
is shown as a mixture of the  5(6)-regioisomers.  
 To apply this labelling technique to model DNA sequences, 
8-nitro-2’-O-methylguanosine (1d) was incorporated into 13-mer, 
27-mer and 37-mer oligodeoxynucleotides. These model 
sequences each contained a single 8-nitroguanine base and 
were prepared using previously reported procedures.8 Reaction 
of the nitro 13-mer sequence (Scheme 5) with a 100-fold excess 
of cysteine thiol (6), in Tris-HCl buffer (pH 8.5) was monitored by 
RP-HPLC. A relatively smooth reaction was observed with 
greater than 90% conversion to the less polar cysteinyl 13-mer  
after 6 hours, together with formation of a small amount of the 
depurinated 13-mer, which runs slightly faster than the nitro-13-
mer (Figure 3, Table 2 for retention times.). The cysteinyl 13-mer 
was isolated by RP-HPLC and was shown by negative mode 
electrospray mass spectrometry to have the expected mass 
(Table 3 in the Experimental section). 
 
 
Scheme 5. Reaction of nitro-13-mer with cysteine nucleophile 6.  
 
Figure 3. RP-HPLC chromatogram showing reaction of 8-nitro-13-mer with 
cysteine derivative 6. Top panel shows the nitro-13-mer starting material and 
the bottom panel shows the reaction mixture after 6 hours. RP-HPLC was 
performed as described in the experimental section using a linear gradient of 
0% to 65% eluent B (blue line) in eluent A, over 19 min, with a flow rate of 1.0 
ml/min. Eluent A = aq TEAB (0.1M), eluent B = 40% CH3CN in aq TEAB 
(0.1M). Chromatograms were recorded at 254 nm. 
 The cysteine nucleophile (6) was also used in 
displacement reactions on the longer 27-mer and 37-mer 
sequences, which are more representative of the naturally 
occurring 8-nitroG lesion in DNA. These reactions were carried 
out under the same conditions as those described for the nitro 
13-mer and although they proceeded more slowly, >90% 
conversion was observed after 11 hours. Both the nitro 27-mer 
and nitro 37-mer were predominantly converted to a single 
product with the expected longer retention times when 
compared to the nitro-containing oligonucleotides (see Table 2 
for retention times). As we were unable to obtain mass 
spectrometry data for the products from these longer oligomers, 
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the presence the 8-S-cysteinyl group in the 27-mer and 37-mer 
was confirmed by enzymatic digestion. Treatment of the product 
oligomers with phosphodiesterase and alkaline phosphatase (pH 
8.5), followed by HPLC analysis showed the presence of 7d in 
the digestion mix, together with the four naturally occurring 2’-
deoxynucleosides. When the chromatogram from the digestion 
mix was analysed to obtain the composition ratios of the 
component nucleosides, the peak area for 7d was lower than 
expected and an unidentified peak, with the UV absorption 
characteristics of a nucleoside (retention time 9.10 min) was 
also observed. It was initially thought that the unidentified peak 
might be a partially digested dinucleotide, but its proportion in 
the digestion mixture increased as the digestion time increased. 
Given that the original cysteine nucleophile (6, retention time = 
19.10 min) could also be detected in the digestion mix, the most 
likely cause of this unidentified nucleoside was hydrolysis of the 
8-S-cysteinyl derivative (7d) to give 8-oxo-2’-O-methylguanosine 
(2b, Figure 1) and releasing (6). A standard of 8-oxo-2’-O-
methylguanosine was prepared31 and it was shown to have the 
same retention time on HPLC as the unidentified nucleoside in 
the digestion mixture, thus implying that 8-S-cysteinyl derivative 
(7d) was breaking down in the digestion mixture.  
 
Table 2 Reverse-phase HPLC retention times (min) for nitro oligomers and 
their reaction products with thiol nucleophiles. HPLC analysis conditions are 
as described in the legend to Figure 3. Nitro-13-mer = d(GCGTA 
CGCATGCG); nitro-27-mer = d(GTGACTGGGAAAACCCTGGCGTTACCC); 
nitro-37-mer = d(GCGCAACGCAATTAATGTGAGTTAGCTCACTCATTAG). G 
= position of 8-nitro-2’-OMe-guanosine. 
Oligomer length nitro-
oligomers 
cysteinyl-
oligomers 
8-fluoro 
oligomers 
13-mer 12.55 14.78 18.63 
27-mer 12.82 14.13 - 
37-mer 12.52 13.74 - 
 
 
 Finally, we wanted to use a fluorescent thiol derivative in 
order to demonstrate the labelling of the 8-nitroG lesion with a 
readily quantifiable reporter group. We chose to use a cystamine 
derivative of carboxyfluorescein (8), which had previously been 
prepared as a mixture of regioisomers and used to label cell-
penetrating oligoguanidinium compounds.30  This fluorescent 
thiol (8) was subsequently used to displace the nitro group in 8-
nitro-2’-O-methylguanosine (1d), using similar conditions to 
those described for the preparation of  (7d, Scheme 4). As the 
fluorescent thiol (8) is a mixture of regioisomers, the resulting 
fluorescein adduct formed  with 8-nitro-2’-O-methylguanosine 
(9d) was more difficult to isolate and characterise than the 8-S-
cysteinyl derivatives, but the identity of the product was 
confirmed by high resolution mass spectrometry. The 
fluorescent thiol (8) was also used to label the nitro 13-mer and 
the resulting fluorescein-tagged 13-mer was isolated by HPLC 
and identified by electrospray mass spectrometry. 
 The mild conditions and clean reaction of the cysteine thiol 
(6) with the nitro 13-mer (Figure 3) and longer sequences, 
clearly indicates the potential for using this reaction to label the 
site of 8-nitroG lesions in DNA. However, whilst the hydrolysis of 
the 8-S-cysteinyl guanosine derivative (7d) during the enzymatic 
digestion was not evident when analysing and manipulating the 
8-S-cysteinyl oligodeoxynucleotides, this reaction does suggest 
that the labelling conditions might have to be optimised to 
eliminate hydrolysis to the 8-oxo guanine nucleoside. The 
observed hydrolytic breakdown of S-guanylated nucleosides 
does suggest a potential additional source of 8-oxoguanosine 
nucleosides/nucleotides in biological systems. 
Conclusions 
These studies reveal that the 8-nitro group exerts a significant 
effect on the reactivity of the guanine base. In particular, the 
reactivity of the guanine NH2 group towards electrophiles is 
significantly reduced, whilst the reactivity of the NH group 
appears to be enhanced, due to its lower pKa. The ease with 
which the nitro group is replaced by thiol nucleophiles under mild 
conditions and the high efficiency of this reaction show that sites 
of guanine nitration in DNA can be fluorescently labelled using 
suitably derivatised thiols. The derivatisation process leaves a 
permanent marker of the original lesion that  can be quantified. 
By using the appropriate thiol (e.g. a thiol derivatised crown 
ether) it should be relatively easy to adapt this labelling 
technique so that the 8-nitroguanine base is converted into a 
current-modulating marker that can be read through nanopore 
sequencing.32  
 Finally, we have shown that reduction of 8-nitroguanosine 
with sodium borohydride in aqueous solution gives 8-
aminoguanosine as the major product, but is also accompanied 
by a denitration reaction to give guanosine. The formation of 
guanosine, in the presence of a hydride equivalent, 
demonstrates that the direct repair of the 8-nitroguanine lesion is 
a chemically feasible reaction.  
 These results significantly enhance our knowledge of the 
chemical properties of this base modification and provide new 
methods to detect and study this lesion.  
Experimental Section 
8-Nitroguanosine (1b) and 8-nitro-2’-O-methylguanosine (1d) were 
prepared as previously described.8 2’3’5’-Tri-O-acetyl-8-nitroguanosine 
(1c) was prepared as described by Saito et al.29(b) N-(tert-
butoxycarbonyl)cysteine ethyl ester (6) was prepared by esterification of 
N-(tert-butoxycarbonyl)cystine.33 8-Oxo-2’-O-methylguanosine was 
prepared from 8-bromo-2’-O-methylguanosine8 following the procedure 
of  Nampalli and Kumar.31 5(6)-Carboxyfluorescein was purchased from  
Sigma-Aldrich as a mixture of 5- and 6-carboxy regioisomers.  
 All RP-HPLC was performed using Gemini™ C18 columns (110 Å, 
250 mm x 4.6 mm) purchased from Phenomenex. RP-HPLC analysis of 
oligonucleotides was performed on an automated Gilson HPLC system 
equipped with an autoinjector, a photodiode array detector and dual 
hydraulic pump, operating with a flow rate 1 ml/min. Chromatograms 
were recorded at 254 nm. Chromatographic data were controlled and 
processed using UniPoint© Version 3.0. All oligonucleotides were purified 
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by RP-HPLC using a triethylammonium bicarbonate (TEAB) buffer 
system. A 1M stock solution of TEAB was prepared by bubbling CO2 
through a 1M aqueous solution of Et3N for 6 – 8 hours until the pH 
measured 7.5 – 7.6. Stock solutions of TEAB were refrigerated until 
needed. All UV measurements were taken on a PerkinElmer Lambda 25 
spectrophotometer. 
 RP-HPLC analysis of 8-nitroguanosine reduction reactions were 
performed on an Agilent 1260 Infinity system equipped with an 
autoinjector, a photodiode array detector and quaternary pump. 
Chromatographic data were controlled and processed using Agilent 
Open LAB Chemstation software. An elution gradient of 0-20% 
acetonitrile in 0.1% aqueous acetic acid over 20 min, with a flow rate of 
0.5 ml/min. Chromatograms were recorded at 254 nm. 
 LC-MS was performed on an Agilent 6530B accurate mass Q-TOF 
G6530B mass spectrometer connected to an Agilent 1260 Infinity HPLC 
system as described above, with a flow rate of 0.5 ml/min. LC-MS data 
was obtained using a multimode ion source and processed using Agilent 
Masshunter software. Spectra were recorded in negative ionisation mode. 
 All NMR spectra were recorded on a Bruker 400 MHz 
spectrometer; 1H (400 MHz) and 13C (100 MHz). All chemical shifts are 
reported in p.p.m. and coupling constants (J) in Hz. 13C spectra were 1H 
decoupled.  1H and 13C chemical shifts are relative to an internal 
standard of tetramethylsilane. Mass spectra of nucleosides and 
chemically synthesised ODNs were recorded on a MicroMass LCT mass 
spectrometer using electrospray ionisation (ES) and direct infusion 
syringe pump sampling. All small molecules were dissolved in methanol. 
Oligonucleotides were dissolved in water and analysed using negative 
mode ES ionisation. 
Table 3. Mass data for all the 13-mer oligonucleotides, obtained by ES 
ionisation as described above. 13-mer sequence = d(GCGTACGCATGCG), G 
= position of modification. 
Oligonucleotide 
Calculated 
exact mass 
Measured 
accurate mass 
8-NitroG-13mer 4050.7025 4050.6133 
Cysteinyl 13-mer 4250.7996 4250.6850 
Fluoroscein 13-mer 4438.7810 4438.7090 
 
Oligodeoxynucleotide synthesis and purification 
Synthesis and purification of 13- and 27- and 37-mer 
oligodeoxynucleotides containing 8-nitro-2’-O-methyl-guanosine was 
performed as previously described.8 All oligodeoxynucleotides containing 
the 8-nitroguanine modification showed the characteristic absorption at 
395 nm. 
Borohydride reduction of 8-nitroguanosine 
8-Nitroguanosine (1.0 mg, 3.05 µmoles) was dissolved in distilled water 
(1 ml) with stirring. Sodium borohydride (5.8 mg, 0.153 mmoles, 50 
equiv) was added, with additional portions (50 equiv) subsequently 
added every 30 mins for 90 mins. Reaction monitored by HPLC, with 
samples taken every 30 mins.. 
8-cysteinyl labelled oligomers  
8-cysteinyl 13-mer = d(GCGTACG(tBu-Cys)CATGCG)                                 
8-cysteinyl 27-mer = d(GTGACTGGG(tBu-Cys)AAAACCCTGGCG-
TTACCC)                                                                                                  
8-cysteinyl 37-mer = d(GCGCAACGCAATTAATGTG(tBu-Cys)AGT-
TAGCTCACTCATTAG) 
To a solution of the appropriate 8-nitro oligomer (3.0 OD (260nm) units) 
dissolved in distilled H2O (100µl) was added 1M TRIS.HCl (pH 8.5,10µl) 
and ethyl N-(tert-butoxycarbonyl)-cysteinate (6, 0.80mg, >100eq). The 
resulting mixture was stirred at 37°C for 6 hours during which time the 
progress of the reaction was monitored by RP-HPLC using a gradient of 
0-26% acetonitrile in TEAB (0.1 M). Retention times for the 
oligonucleotide substrates and products are presented in Table 2. 
Oligonucleotide products were purified using the same gradient and the 
fractions containing the products were evaporated 3 times with distilled 
water in a vacuum centrifuge.  
8-Fluoroscein labelled oligomer  
8-Fluoroscein 13-mer = d(GCGTACG(Fluro)CATGCG). To a solution of the 
8-nitro 13-mer (3.1 OD units) dissolved in distilled H2O (100µl) was 
added 1M TRIS.HCl (pH 8.5, 10µl) and 3’,6’-dihydroxy-3-oxo-N-(2-
sulfanylethyl)-3H-spiro[2-benzofuran-1,9’-xanthene]-5(6)-carboxamide (8, 
1.7mg). The resulting mixture was stirred at 37°C for 24 hours during 
which time the progress of the reaction was monitored by RP-HPLC 
using a gradient of 0-26% acetonitrile in TEAB (0.1 M). Retention times 
for the oligonucleotide substrates and  products are presented in Table 2. 
Oligonucleotide products were purified using the same gradient and the 
fractions containing the products were evaporated 3 times with distilled 
water in a vacuum centrifuge. 
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